Literature DB >> 10511612

Nephropathy in patients with type 2 diabetes mellitus.

E Ritz1, S R Orth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10511612     DOI： 10.1056/NEJM199910073411506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  164 in total

Review 1.  Pathogenesis of diabetic nephropathy.

Authors:  Claudia van Dijk; Tomas Berl
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Reducing potentially avoidable complications in patients with chronic diseases: the Prometheus Payment approach.

Authors:  Francois De Brantes; Amita Rastogi; Michael Painter
Journal:  Health Serv Res       Date:  2010-12       Impact factor: 3.402

Review 3.  Microvascular complications: pathophysiology and management.

Authors:  Karunakaran Vithian; Steven Hurel
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

4.  Prevalence of mild impairment in renal function in a random sample of elders from a biethnic community survey.

Authors:  R D Lindeman; L J Romero; C L Yau; R N Baumgartner; P J Garry
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 5.  [Early diagnosis of chronic kidney diseases].

Authors:  E Schulze-Lohoff; T Matthäus; M Weber
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

Review 6.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 7.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 8.  Combating diabetic nephropathy with drug therapy.

Authors:  D Martins; K Norris
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

9.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

Review 10.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.